News Release

NSF awards Georgetown University $12.5m to establish institute for emerging virus research

Grant and Award Announcement

Georgetown University Medical Center

WASHINGTON (August 10, 2022) -- The National Science Foundation has awarded Georgetown University $12.5 million to lead a global team of scientists in establishing a collaborative institute designed to advance research and education around viral emergence -- the process of viruses jumping from animals to humans.

The Verena (Viral Emergence Research Initiative) Biology Integration Institute, based at Georgetown’s Center for Global Health Science and Security, aims to advance a cross-disciplinary research agenda that targets significant sources of emerging infectious diseases. The collaboration will also train scientists at all career stages in the science of the host-virus network, as well as core scientific skills in data fluency and boundary spanning, creating the next generation of viral emergence-focused researchers.

“The days of ‘quiet periods’ between epidemics are over - from this point on, we’re headed from Covid-19 straight into monkeypox, into the next public health crisis,” says Georgetown assistant professor Colin Carlson, PhD, director of the Institute and co-founder of Verena. “Our goal is to build the data and tools we need to know what’s coming tomorrow–and maybe, actually, be ready next time.”

Carlson and four additional co-investigators will lead the institute’s theme-related work streams including:

  • Carlson - “Transmission and the emergence of ecological dynamics;”
  • Daniel Becker, PhD, University of Oklahoma - “The coevolution of host immunity and the global virome;”
  • Stephanie Seifert, PhD, Washington State University - “ Host and virus-omics and the rules of compatibility;” and,
  • Sadie Ryan, PhD, University of Florida - “Global change and the emergence of new host-virus interactions.”

Cynthia Wei, PhD, an associate teaching professor in Georgetown’s Walsh School of Foreign Service, will serve as the institute’s lead on training and education. The institute also includes 9 additional senior researchers.

Over the first five years, the NSF-funded Institute will provide new insights into the evolution of bats’ unique immune systems, and—with additional exploratory work on mosquito vectors of disease—will lay the foundation to apply innovative methods across the vertebrate and invertebrate global virome. In addition, the predictive work undertaken by the team will spark broad advances in machine learning and computational biology. The open data infrastructure being developed—including a universal, public database for wildlife disease surveillance—will broaden the horizons of quantitative work in disease ecology at large.

“We started developing our approach six months before the pandemic started: we build datasets, run experiments, and apply artificial intelligence all in concert to understand the rules of cross-species transmission,” Carlson explains. “Three years in, we’re thrilled at the chance to scale up and tackle even harder problems—and hopefully start to make real impacts in global health and conservation.”

Training scientists in the cross-disciplinary methods used by the team will also be a significant part of the overall project, with more than 100 undergraduate and graduate students being trained in the first five years.

“Students will have chances to connect with and learn from a sharp, diverse, and vibrant group of researchers, as well as unique opportunities to engage in Verena research,”  says Georgetown’s Wei, the training and education lead. “These experiences will provide an exciting window into the process of collaborative, interdisciplinary, and actionable science. They will also provide a chance for students to be a part of cutting-edge discoveries on viral emergence.”

These training opportunities add to Georgetown’s already-extensive work in pandemic prevention and preparedness, including the Center for Global Health Science & Security’s (GHSS) work in this space.

“This is an incredibly exciting award and we anticipate the work will be transformative to the entire field,” says GHSS director Rebecca Katz, PhD, who also serves as chair of Verena’s Science-Policy Advisory Board.



The co-investigators report having no personal financial interests related to the Institute’s work.

National Science Foundation “BII: Predicting the global host-virus network from molecular foundations” (#2213854)

About Georgetown University Medical Center

As a top academic health and science center, Georgetown University Medical Center  provides, in a synergistic fashion, excellence in education — training physicians, nurses, health administrators and other health professionals, as well as biomedical scientists — and cutting-edge interdisciplinary research collaboration, enhancing our basic science and translational biomedical research capacity in order to improve human health. Patient care, clinical research and education is conducted with our academic health system partner, MedStar Health. GUMC’s mission is carried out with a strong emphasis on social justice and a dedication to the Catholic, Jesuit principle of cura personalis -- or “care of the whole person.” GUMC comprises the School of Medicine, the School of Nursing, School of Health, Biomedical Graduate Education, and Georgetown Lombardi Comprehensive Cancer Center. Designated by the Carnegie Foundation as a doctoral university with "very high research activity,” Georgetown is home to a Clinical and Translational Science Award from the National Institutes of Health, and a Comprehensive Cancer Center designation from the National Cancer Institute. Connect with GUMC on Facebook ( and on Twitter (@gumedcenter).

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.